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The ability of glycogen, the depot into which excess glucose is stored in mammals,
to act as a source of rapidly available energy substrate, has been exploited by
several organs for both general and local advantage. The liver, expressing the highest
concentration of glycogen maintains systemic normoglycemia ensuring the brain
receives a supply of glucose in excess of demand. However the brain also contains
glycogen, although its role is more specialized. Brain glycogen is located exclusively in
astrocytes in the adult, with the exception of pathological conditions, thus in order to
benefit neurons, and energy conduit (lactate) is trafficked inter-cellularly. Such a complex
scheme requires cell type specific expression of a variety of metabolic enzymes and
transporters. Glycogen supports neural elements during withdrawal of glucose, but
once the limited buffer of glycogen is exhausted neural function fails and irreversible
injury ensues. Under physiological conditions glycogen acts to provide supplemental
substrates when ambient glucose is unable to support function during increased energy
demand. Glycogen also supports learning and memory where it provides lactate to
neurons during the conditioning phase of in vitro long-term potentiation (LTP), an
experimental correlate of learning. Inhibiting the breakdown of glycogen or intercellular
transport of lactate in in vivo rat models inhibits the retention of memory. Our current
understanding of the importance of brain glycogen is expanding to encompass roles
that are fundamental to higher brain function.
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INTRODUCTION
The lack of appreciation for the role(s) that brain glycogen contributes to brain function
cannot be attributed to its recent discovery, as its presence, detected by both biochemical assay
(Koizumi, 1974) and electron microscopy (Koizumi and Shiraishi, 1970), has been known for
decades. Unlike skeletal muscle or liver, where glycogen is expressed uniformly throughout a
homogenous cell population (Stryer, 1995), the cellular (and sub-cellular) location of glycogen
within the brain provides clues to its function (Cataldo and Broadwell, 1986; Oe et al., 2016),
but detailed information regarding the intricacies of metabolic cell-to-cell signaling within the
brain (Dringen et al., 1995; Magistretti and Pellerin, 1997; Dienel, 2009) were required before
potential roles for glycogen could be proposed and experimentally tested (Brown et al., 2003;
Suzuki et al., 2011). This disregard for brain glycogen was compounded by the low concentration
with which glycogen is expressed in the brain; up to 100 times lower than liver and skeletal muscle
(Stryer, 1995). Although never consigned as a vestigial entity glycogen was quietly ignored, and
in a neurocentric world there were few advocates proposing it warranted detailed investigation.
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SYSTEMIC HYPOGLYCEMIA
The presence of glycogen in the brain may be viewed as at
odds with established facts regarding whole body metabolism.
Given the brains exclusive reliance on glucose as its sole
energy support, and the complex endocrine machinery that
secures blood glucose levels within a narrow concentration
range (Frier and Fisher, 2007), any need for glycogen within
the brain initially seems superfluous. The liver breaks down
glycogen in response to falling systemic glucose levels ensuring
adequate delivery of glucose to the brain for up to 24 h (Stryer,
1995). Skeletal muscle glycogen provides a localized energy
reserve for muscle (Champe and Harvey, 2008; although
even this is a simplification, with recent studies suggesting
a highly complex and coordinated reciprocal metabolism of
glucose and lactate between brain and muscle, dependent
upon immediate localized requirements; Dalsgaard et al., 2004;
Dalsgaard, 2006). What is not in doubt is the exquisite sensitivity
that the brain displays when confronted with a shortfall in
glucose delivery (Frier and Fisher, 2007). Consistent with the
homeostatic hormonal response that maintains normoglycemia,
in event of decreased systemic glucose (hypoglycemia) the
brain responds via the autonomic nervous system, with a
series of signals (sweating, tremor, decreased temperature,
decreased intraocular pressure, increased gastric emptying)
that warn the sufferer of an impending hypoglycemic attack
(Frier and Fisher, 2007). The critical aspect of this autonomic
response is that its threshold lies above that of the glycopenic
symptoms (confusion, drowsiness, odd behavior, speech
difficulty, lack of co-ordination) of hypoglycemia characterized
by confusion. However repeated hypoglycemic episodes
compromise the threshold for the autonomic symptoms,
a process called hypoglycemia unawareness (Cryer, 2002),
such that they dip below those of the glycopenic effects
rendering the sufferer incapable of responding appropriately
to the hypoglycemia, with potentially fatal consequences
(Figure 1).
GLUCOSE IS THE MAIN ENERGY
SUPPORT FOR BRAIN FUNCTION
In the last 20 years attempts to deduce the role(s) of brain
glycogen have been played out against a background of
confusion, dead ends and polarized opinion, which stems from
the simple fact that we know little about critical aspects of
metabolism in the brain at the cellular level (Ames, 2000). The
scenario can be simplified as follows; we do not know which
energy substrates cells use under particular conditions. This
rather simplistic statement conceals a degree of complexity that
is initially difficult to appreciate when one considers that all
we are considering is which of two energy substrates (glucose
or lactate) two cell types (neurons and glia) use. To begin
to unravel this, we must first review evidence that led to
the dogmatic view of brain energy metabolism, which states
that glucose is the energy substrate used by all cells in the
brain (Dwyer, 2002). This has substantial support based on the
following facts: (1) during insulin-induced hypoglycemia there
FIGURE 1 | Blood glucose levels associated with hypoglycemia. Blood
glucose below 4 mM is considered hypoglycemic (1), with autonomic
symptoms (2) triggered at about 3 mM and glycopenic symptoms triggered at
about 2 mM (3). However the condition hypoglycemia unawareness leads to a
fall in the threshold of the autonomic symptoms below that of the glycopenic
threshold (4). Adapted from Figure 7.1 (Frier and Fisher, 2007).
is no systemic alternate energy substrate that can substitute
for glucose; (2) complex homeostatic mechanisms have evolved
to maintain normoglycemia (no such equivalent systems exist
for alternate substrates such as lactate); (3) non-glucose
substrates are converted, in the process of gluconeogenesis, into
glucose, implying glucose is a universally preferred substrate;
(4) metabolites of glucose are detected in the brain using NMR
spectroscopic methods; and (5) the arterial-venous difference
for brain glucose is positive, implying glucose uptake into
the brain. Although it has been known for decades that
the brain releases lactate (Abi-Saab et al., 2002), historically
this was considered a waste product of glucose metabolism,
and of no metabolic consequence. This dismissal of lactate
as a viable energy substrate was reconsidered in the face
of evidence that suggested it might be actively taken up
and metabolized by neurons. However the conditions under
which this would occur were obscured due to the technical
difficulties involved in measuring energy usage in single cells.
An additional complication is the role that glycogen plays.
Glycogen, the storage form of glucose in the body (Champe and
Harvey, 2008), is a molecule comprising dehydrated glucosyl
molecules, which can be liberated as lactate (Shulman et al.,
2001).
SUB-CELLULAR LOCATION OF
GLYCOGEN
Since the advent of the electron microscope it has been known
that in the adult rodent brain glycogen is stored almost
exclusively in astrocytes (Cataldo and Broadwell, 1986). Due to
a lack of appreciation of the role that glial cells contribute to
brain function that was prevalent in previous decades, such a
location for glycogen, compounded by its low concentrations,
led to dismissal of any importance attached to the compound
(Stryer, 1995). We should not judge our predecessors for
their lack of insight, as it is only in recent years, where the
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intercellular metabolic signaling pathways have been identified,
that a role for glycogen has become apparent (Brown et al.,
2003; Suzuki et al., 2011). Initial studies, which reported that
glycogen was located in astrocyte processes abutting synapses
(Koizumi and Shiraishi, 1970; Phelps, 1972; Koizumi, 1974), have
been confirmed with more advanced microscopic techniques
that allow 3D reconstruction of very fine astrocytic processes
(Cali et al., 2016). These studies suggest not only an intimate
relationship exists between astrocytes and neurons, but in
particular between astrocytes and synapses, with mitochondria
expressed in high density in these processes (Cali et al.,
2016).
Until recently the regional expression of brain glycogen
was unclear. This was primarily because the technique used
to assess glycogen expression (biochemical glycogen assay) was
incapable of the resolution required to accurately measure the
glycogen concentration in small areas of brain (Passonneau
et al., 1967). A refined technique that uses immunohistochemical
assessment of glycogen has recently been used to accurately
visualize glycogen expression throughout the rodent brain (Oe
et al., 2016). The report confirmed that in the adult glycogen
is expressed almost exclusively in astrocytes and is located
in the astrocytic processes rather than in the soma. The
highest expression of glycogen occurred in the hippocampus,
striatum, cortex and cerebellar molecular layer, a region of
high synaptic activity, but was lower in white matter and
sub-cortical areas. It is interesting to note that the regions with
the highest expression of glycogen also have higher metabolic
demand.
The dogmatic view of an exclusively astrocytic domain
for glycogen must be considered against the evidence of
neuronally located glycogen. Such a location was associated
with pathological conditions such as Lafora’s disease, a form of
epilepsy, where such an over-abundance of neuronal glycogen is
considered a side effect of the disease and has no physiological
function (Vilchez et al., 2007). In the sciatic nerve glycogen
related enzymes are shown to be present in axons (Pfeiffer-
Guglielmi et al., 2006, 2007), and glycogen is present in both
axons and Schwann cells, but only under pathological conditions
(Powell et al., 1985; Katsuragi et al., 1988; Kalichman et al.,
1998). A recent article has described neuronal glycogen that
acts to protect axons during periods of hypoxia, as glycogen
phosphorylase (GP) is present in nerves facilitating glycogen
metabolism (Saez et al., 2014).
ASTROCYTIC SUPPORT OF CULTURED
NEURONS
Initial studies that investigated the role of neuronal cells
were carried out in tissue culture conditions. This reductionist
approach was justified in the light of the difficulty of gaining
meaningful data from in situ tissue (Kettenmann and Grantyn,
1992). These studies yielded bountiful information, but it was
only as the studies progressed that questions were raised
as to their validity i.e., did what occurred in the artificial
nature of the tissue culture dish have any relation to what
occurred in vivo. A key example of this was the viability
of neurones in culture, where the yield of neurones cultured
in isolation was poor. As the neurones cultured were from
neo-natal animals, these neurones had to develop in the
absence of any support from the in vivo environment they
would normally develop in. Glial cells were added to the
culture in an attempt to increase neurone yield, which did
indeed occur although the reasons were unknown (Whatley
et al., 1981). We now know that neurones are reliant on
glial cells for a multitude of reasons; release of trophic factors
to guide developing neurones, to provide myelin, to buffer
extracellular compounds such as potassium and glutamate.
In addition the extracellular space is essentially infinite in
culture conditions, whereas in vivo it is relatively small (15%
of brain volume) and provides a very small buffer zone
between neighboring cells (Swanson and Choi, 1993). However
studies using tissue culture from the Waagepetersen laboratory
confirm that glia-neuron transfer of metabolites interactions can
occur (Sickmann et al., 2005). The glia and other surrounding
neurones would also provide structural support to maintain
the neuron in a fixed location within the brain parenchyma.
Although not the focus of this review, oligodendrocytes are
implied to play a role in supplying lactate to axons (Lee et al.,
2012).
Whereas the behavior of neurones may have been
compromised in tissue culture conditions, it was a serendipitous
approach that yielded preliminary information on the metabolic
support afforded neurones by astrocytes (Swanson and Choi,
1993). Neurones that were co-cultured with astrocytes displayed
increased viability compared to neurones that were cultured in
isolation. However it was discovered that it was the presence
of glycogen in the astrocytes that was the critical factor in
promoting neuronal survival, as astrocytes with depleted
glycogen did not significantly prolong neuronal survival
(Swanson and Choi, 1993). This was an intriguing result that
posed more questions than it answered, most notably, what was
the form in which glycogen provided support?
THE ROLE OF GLYCOGEN DURING
AGLYCEMIA
From studies of glycogen in the liver and skeletal muscle the
nature of the glycogen molecule and its regulation are well
established (Stryer, 1995), information that can reasonably be
applied to brain glycogen. In the periphery glycogen acts as
a storage depot for excess glucose during periods of plenty,
to be liberated in time of need. In the liver glycogen is
liberated in the form of glucose to maintain normoglycemic
blood glucose levels (Stryer, 1995), whereas in the muscle
glycogen is glycolytically metabolized (Stryer, 1995), with the
apparent waste product lactate liberated into the bloodstream.
The nature of the support offered by astrocytic glycogen to
neurons was presumably metabolic, thus how this was achieved
was a prime focus of investigation. The simplest explanation was
that glycogen supported solely astrocytes, relieving the metabolic
burden from neurones, i.e., astrocytes are fueled exclusively be
glycogen sparing interstitial glucose for exclusive use by neurons
(DiNuzzo et al., 2010). Whilst this is a theory as simplistic as it
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is attractive, it is not the case. Studies carried out in cultured
astrocytes indicated that when astrocytes were incubated in the
presence of glucose they released lactate (Dringen et al., 1993b),
whereas neurones did not release lactate; in fact they consumed
it (Dringen et al., 1993a). This indicated that astrocytes might
release lactate, which is then taken up and used by neurons
as an energy substrate to supplement glucose uptake (Dringen
et al., 1993a). This is where the origins of a contentious and
continuing dispute arose. Whilst it can be insightful to study how
processes work under tissue culture conditions, they may not
apply in vivo. This is especially important where the interstitial
compartment is proposed to be the medium of exchange through
which putative metabolic compounds are passed from astrocyte
to neurons. However under tissue culture conditions where the
interstitial space is infinitely large, this is unrealistic and alternate
models were required.
Given the complexity of metabolic interactions in gray matter
the Ransom lab chose to use a simple white matter model, the
rodent optic nerve, to investigate the role of glycogen (Ransom
et al., 1994). These studies were prompted by comparison of the
effects of anoxia or aglycemia on the stimulus evoked compound
action potential (CAP). The tissue is accessible to recordings
of the stimulus evoked CAP, a monitor of axon conduction,
whose area is proportional to the number of conducting axons
(Cummins et al., 1979). The CAP area recorded in 10 mM
glucose provides a baseline measure of axon conduction against
which the post-insult CAP can be compared (Stys et al.,
1991). In addition to electrophysiological recordings, the tissue
is amenable to biochemical assay, simultaneous recordings
of lactate release from the tissue and immunohistochemical
staining. In the presence of oxygen but with glucose withdrawn
(aglycemia) the CAP lasted up to 30 min before failing (Ransom
and Fern, 1997). This suggested that there was an endogenous
energy reserve present within the tissue that supported axon
conduction in the absence of exogenously applied glucose, but
that the reserve was limited and could only support conduction
for a limited period of time; once the reserve was exhausted
conduction failed. The most likely candidate for this energy
reserve is glycogen, which has been located in astrocytes by
electron microscopy in both the rat (Wender et al., 2000) and
mouse optic nerve (MON; Brown et al., 2003). Given that
glycogen supports axon conduction in the absence of glucose,
one would reasonably predict that increasing glycogen content
should increase the latency to CAP failure, whereas depleting
glycogen content would attenuate latency to CAP failure, during
a subsequent period of aglycemia. This was indeed found to
be the case (Brown et al., 2003). The macromolecule glycogen
is too large to be transported intercellularly, thus there must
exist a glycogen-derived metabolic conduit that supports axon
conduction. This is most likely lactate, since astrocytes in culture
release lactate in the presence of glucose (Dringen et al., 1993a,b).
If lactate were released from the breakdown of glycogen, then
lactate, in the absence of glucose, should be able to support
MON axon conduction. In addition, blocking lactate release
from astrocytes, or uptake into axons with pharmacological
blockers should also attenuate the CAP: all of these predictions
were shown to occur experimentally (Brown et al., 2003;
Tekkok et al., 2005). Immunohistochemical studies to investigate
the presence of monocarboxylate transporters (MCTs) on
cells membranes, demonstrated MCT1 immunoreactivity on
astrocyte membranes and MCT2 immunoreactivity on axon
membranes (Tekkok et al., 2005). The MCTs facilitate the
movement of lactate across cell membranes, thus their presence
is an absolute requirement for trans-membrane flux of lactate.
Preventing glycogen breakdown by pharmacologically inhibiting
GP also attenuated the latency to CAP failure during aglycemia
(Brown et al., 2004; Figure 2).
The sciatic nerve was studied in order to determine whether
there was an equivalent metabolic cell-to-cell signaling pathway
in the peripheral nervous system (PNS). Electron microscopic
images revealed that Schwann cells did express glycogen, which
was measured by biochemical assay at a concentration about
twice that in the optic nerve (Brown et al., 2012). The sciatic
nerve contains two broad classes of axons, large myelinated
A fibers, and smaller unmyelinated C fibers grouped within
Remak bundles (Landon, 1976). Introduction of aglycemia
resulted in the C peak failing within about 30 min, whereas the
larger myelinated A fibers could sustain conduction for up to
two and a half hours before they began to fail (Brown et al.,
2012). Such a difference could in part be related to the greater
metabolic rate of small axons (per unit volume) compared to
FIGURE 2 | Glycogen storage in the astrocyte. Glucose is taken up by
astrocytes via the GLUT-1 glucose transporter, where it is phosphorylated by
hexokinase (HK) to glucose-6-phosphate (G-6-P). The G-6-P can either
proceed along the glycolytic pathway, or be added to the glycogen molecule
by glycogen synthase (GS). The glycogen is broken down by glycogen
phosphorylase (GP), ultimately to lactate, which crosses the astrocyte
membrane by monocarboxylate transporter (MCT). Adapted from Figure 1
(Fryer and Brown, 2015).
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FIGURE 3 | Glycogen content determines latency to failure in optic
nerve axons and Schwann cell A fibers but not C fibers. (A) In mouse
optic nerve (MON) glycogen content determines latency to failure during
subsequent period of aglycemia (4). (B) In Schwann cells elevated glycogen
content benefits A fibers () but not C fibers (4). Note elevated (glycogen)
does not prolong C fiber latency to failure. Adapted from Figure 2 (Brown
et al., 2003) and Figure 5 (Brown et al., 2012).
larger axons (Perge et al., 2012). However when glycogen content
was increased there was no increase in the latency to failure
in the C peak, whereas the latency to failure of A fibers was
increased (Figure 3). Thus glycogen expressed in Schwann cells
only benefitted the A fibers and had no effect on the C fibers.
Glycogen was broken down to lactate in the Schwann cell and
transported intercellularly via MCTs (Domènech-Estévez et al.,
2015) to the A fibers (Brown et al., 2012). Thus, there are striking
similarities between the central and PNSs with regard to the
metabolic provision of glycogen-derived lactate, where glycogen,
located in glial cells, is broken down to lactate, which acts as a
metabolic conduit to support axon conduction during periods of
shortfall in glucose delivery to the tissue. However what is more
physiologically relevant is the role(s) that glycogen plays under
normal, non-pathological conditions, thus the next logical step
in the MON studies was to investigate the role of glycogen in
supporting physiological activity.
THE ROLE OF GLYCOGEN DURING HIGH
FREQUENCY STIMULUS
Imposing a short period of high intensity stimulus was very
effective at revealing key information. At frequencies between
10 Hz and 100 Hz, i.e., an action potential was evoked between
every 100 ms and 10 ms, the increasing metabolic demand
imposed on the tissue exceeded its ability to support conduction,
in the presence of 10 mM glucose aCSF (Brown et al., 2003). In
the first instance imposing a 4 min period of 100 Hz stimulus
on the MON caused an elongation of the CAP profile, no
doubt due to accumulation of interstitial K+ (Connors et al.,
1982) exceeding the ability of the Na+-K+ ATPase to maintain
homeostatic trans-membrane ion concentrations (Ransom et al.,
2000), but the CAP area did not fall below baseline (Brown
et al., 2003). However a decrease in glycogen content after only
4 min of the high intensity stimulus occurred in the presence
of 10 mM glucose (Brown et al., 2003), suggesting that even
this high concentration of glucose was unable to support the
CAP, and glycogen derived lactate was released as a supplemental
energy substrate. Extended exposure to 100 Hz stimulus (on
the order or tens of minutes) caused a decrease in the CAP
area that could be reversed if the MON was supplied with
30 mM glucose aCSF (Brown et al., 2003). This reveals a
very important point, which is that the MON will continue to
conduct action potentials during periods of increased energy
demand if excess substrate is applied, i.e., if the increased
energy demand required by the increased stimulus is met by
increased supply of energy substrate then CAP conduction
will be maintained. Thus, there is no absolute threshold with
regard to conduction failure; rather it is determined on the
basis of whether the energy demand is matched by supply of
substrate. This point was further demonstrated by exposing
MONs to 2 mM glucose aCSF. Under baseline conditions of
stimulus every 30 s the CAP area was maintained at baseline
levels. However depleting glycogen with a short period of
exposure to 0 mM glucose resulted in subsequent exposure
to 2 mM glucose being unable to support conduction (Brown
et al., 2003), implying that under hypoglycemic conditions
supplementary glycogen-derived lactate is required to fully
support function. The relationship between the ability of the
MON to support conduction under the duress of increased
energy demand was shown when MONs were exposed to
100 Hz stimulus in 2 mM glucose, where the CAP fell
rapidly on imposition of the stimulus (Brown et al., 2003).
These experiments provided the first information regarding
potential role(s) of glycogen under physiological conditions,
namely to act as an energy buffer to supply substrate during
short-term mis-match between ambient glucose and energy
demand.
A key issue that was missing from these studies was
identification of the signaling mechanism whereby neurones
inform astrocytes of their metabolic requirements. Such a
mechanism would have to adhere to the following requirements:
(1) it must be localized; (2) it must be capable of invoking
rapid glycogen breakdown; (3) the intensity of the signal must
be proportionate to the stimulus intensity; (4) the intensity of
the signal must dissipate as the stimulus intensity declines; and
(5) if the signal is not universal, then comparable localized
equivalent systems must exist across the nervous system. A
potential mechanism was revealed via studies investigating the
neurotransmitter modulation of glycogen content.
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THE ASTROCYTE NEURON LACTATE
SHUTTLE HYPOTHESIS
One important aspect of glycogen’s metabolism in the brain is
the means by which it is modified. Whereas in the periphery
glycogen is modulated by the hormones insulin and glucagon,
in the brain parenchyma the influence of these hormones
appear to be attenuated and neurotransmitters contribute
regulatory roles. Pierre Magistretti’s group started investigating
this phenomenon in the early 1990’s. Their goal was to identify
physiologically relevant modulators, and these initial studies
identified VIP, nor-epinephrine and adenosine as well as K+
(see later) as controlling glycogen levels (Hof et al., 1988;
Sorg and Magistretti, 1991). However their studies investigating
the putative modulatory role of the most abundant excitatory
CNS neurotransmitter, glutamate, yielded unexpected results
that were adapted as the basis of the astrocyte neuron lactate
shuttle hypothesis (ANLSH; Pellerin and Magistretti, 1994).
This hypothesis had its origins in studies carried out in the
honeybee retina, which is metabolically and morphologically
compartmentalized. Light stimulus induces glucose uptake in
the honeybee retinal glial cells, but these cells show no
increased oxygen uptake. However the photoreceptors take
up alanine derived from the astrocytic glucose and increase
oxygen consumption (Tsacopoulos et al., 1994). This metabolic
compartmentalization clearly displays a division of labor between
glial cells and neurons, in which the glial cells take up glucose
and glycolytically convert it to alanine, which is then transported
to the photoreceptors via the interstitial space for oxidative
metabolism. Magistretti and Pellerin (1997) work proposed a
similar compartmentalized scenario in the mammalian brain,
which is set in motion when neuronal activity results in
elevated interstitial glutamate. The glutamate is co-transported
with Na+ into the astrocyte, where the glutamate is converted
to glutamine, then shuttled to the neurones for conversion
to glutamate by glutaminase. However the excess Na+ must
be pumped out of the astrocyte via the Na+-K+ ATPase
and conversion of glutamate to glutamine requires ATP. The
energy debt is met via astrocytic uptake of glucose followed
by glycolytic conversion to lactate, yielding two molecules of
ATP. One molecule of ATP fuels the Na+-K+ ATPase, the
other glutamate conversion. The product of the glycolysis,
lactate, is then transported out of the astrocyte and into
the neurone where it is oxidatively metabolized (Pellerin and
Magistretti, 1994). This is a superficially stoichiometrically
pleasing scheme but has come in for intense scrutiny, key
criticisms being that this scheme obviously only applies to
glutamatergic brain areas; what occurs, for example, in white
matter, and if all glucose and glycogen goes to lactate what fuels
other processes? The debate is too convoluted and voluminous
to describe in detail here, but the following reviews may be
consulted to provide a balanced view of both sides of the
argument with those opposed to the hypothesis proposing
arguments that cannot be ignored (Chih et al., 2001; Dienel and
Hertz, 2001; Chih and Roberts, 2003; Pellerin and Magistretti,
2003, 2012; Aubert et al., 2005; Dienel, 2010; DiNuzzo et al.,
2010).
ELEVATED INTERSTITIAL K+ PROMOTES
GLYCOGENOLYSIS
A recent study has linked elevations in extracellular K+, as
would occur during increased neuronal activity, to promotion
of astrocytic glycogenolysis (Choi et al., 2012). This is a
more universally applicable mechanism as all neurons/axons,
be they central or peripheral, release K+ into the interstitium
as a result of activity (Kandel et al., 2000). The greater the
intensity of the activity the greater the increase in K+, and
as demonstrated in rat optic nerve the K+ increase in the
interstitium is buffered very efficiently by astrocytes (Ransom
et al., 2000), and retreats towards baseline in the order of
seconds. In the sciatic nerve the stimulus induced increases
in K+ are attenuated, and the elevations persist for longer,
suggesting less efficient buffering than occurs in central tissue
(Hoppe et al., 1991). The interstitial K+ activates a Na+-HCO3−
co-transporter on the astrocyte membrane, whose activation
results in intracellular alkalization. This change in intracellular
HCO3 results in increased soluble adenylyl cyclase (sAC) activity,
an enzyme that causes elevated cAMP, leading to glycogenolysis,
and production of intracellular lactate (Choi et al., 2012).
The lactate is transported out the cell to the neurones, where
it acts as an energy substrate for oxidative phosphorylation
(Figure 4).
In a complementary study interstitial K+ elevations were
shown to have a separate but related effect, activating a channel
on the astrocyte membrane through which pools of astrocytic
lactate could flow into the interstitium, in parallel with the
established route of MCTs (Sotelo-Hitschfeld et al., 2015). This
is a very important route for astrocytic lactate release, since
it is coupled to the membrane potential and allows lactate
release against a concentration gradient, whereas the MCT is
electro-neutral and net flux is governed by the trans-membrane
concentrations of H+ and lactate (Figure 5).
GLYCOGEN AND MEMORY
It is germane at this point to reflect upon the properties of
glycogen and how these can confer certain metabolic advantages.
Glycogen is an energy buffer, present in astrocytes that can
be mobilized rapidly, without the need to expend ATP, as is
the case with glucose. As such glycogen stands as a readily
metabilizable energy source that would rapidly provide energy
substrate. Compare this to glucose, which is delivered via
the blood stream implying delivery of excess glucose would
require delivery of excess blood, a process called functional
hyperemia. This is a comparatively slow process (Gordon et al.,
2008), and would be unable to deliver the instant energy
required by neurones. This is worth bearing in mind in the
following discussion of the role of glycogen during memory
formation.
In studies dating back two decades the role of glycogen in
supporting one of the most important brain functions, learning
and memory commenced. Learning and memory are functions
that can be tested in live animals via a series of standard tests
(Kandel et al., 2000). The underlying cellular mechanisms are
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FIGURE 4 | Interstitial K+ stimulates astrocytic glycogenolysis. Increased neural activity promotes elevated interstitial K+, which activates the Na+-HCO3−
coupled transporter leading to alkalization of the astrocyte cytoplasm. This activates soluble adenylyl cyclase (sAC), which in turn elevates cytoplasmic cAMP leading
to glycogenolysis and transfer of lactate out of the astrocyte for neuronal oxidative metabolism. Adapted from Figure 7 (Choi et al., 2012).
rather more difficult to pin down, but in a variety of animal
models, including chick and rats, these have been ascribed to
long-term potentiation (LTP) in the hippocampus. This process
is quantifiable by using electrophysiological techniques, where a
brief, high frequency conditioning stimulus is applied to axonal
input to the CA1 pyramidal cell dendritic field. The resulting
synaptic response is enhanced post-conditioning, an indication
of ‘‘learning’’ occurring at the synapse (Malenka, 2003). The
initial studies took place with the chick as the animal model.
The chick was exposed to two beads, red or blue in color.
The red bead was coated in an aversant compound and the
chicks choice of pecking was noted. The ratio between the
number of pecks of red beads and blue was measured, with
an increased ratio indicative of red bead avoidance and hence
learning (Hertz et al., 1996). The concentration of glycogen in the
forebrain decreased concomitant with an increase in glutamate
(Hertz et al., 2003). The learning process could be attenuated by
inhibiting glycolysis or glycogenolysis and restored by applying
exogenous aspartate and acetate, which is metabolized in the
astrocytes, or application of glutamine (Gibbs et al., 2006a,b).
These studies demonstrated robust learning in the chick, which
appeared to involve breakdown of glycogen to ultimately produce
glutamate.
The main findings of these chick experiments were extended
in studies on rodents to encompass not only live animal studies
on learning and memory, but investigation of the cellular
FIGURE 5 | Interstitial K+ promotes astrocytic lactate release via the lactate channel. As described in Figure 4, neural activity results in elevated interstitial
K+. This activates a channel leading to release of the cytoplasmic lactate pool into the interstitium, which, via a positive feedback loop, causes further lactate release.
Adapted from Figure 8 (Sotelo-Hitschfeld et al., 2015).
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mechanism underlying these processes using in vitro techniques.
Rats were placed in a white chamber, separated from another
chamber by a door. The experimenter opened the door, and
when the rat entered the new chamber it received an electric
footshock, and was then placed back in the white chamber. The
time taken for the rat to re-enter the second chamber was taken
as an index of memory, with increased latency signifying that
the rat had learned to avoid the chamber (Taubenfeld et al.,
2001). The rats were tested daily after the conditioning shock,
and the latency to re-enter the second chamber was stable at
about 300 s for up to 7 days. Injection of the GP inhibitor
DAB into the rat’s brain decreased the latency indicating that
memory was impaired. Exogenously dialyzed lactate into the
hippocampus circumvented the inhibitory effects of DAB and
augmented the latency. Electrophysiological recordings of LTP
in hippocampal slices showed that in the presence of DAB the
synaptic efficacy was initially enhanced, but this rapidly fell,
indicative of no long-term enhancement of synaptic efficacy
occurring (Suzuki et al., 2011). These data confirm a role for
glycogen in the process of memory. This data appears to suggest
there is a metabolic aspect to LTP, that glycogen-derived lactate
is an integral component of the process (Suzuki et al., 2011).
The speed with which glycogen can be metabolized makes it
an ideal energy buffer, capable of rapid delivery of lactate to
the neuronal elements that exhibit very rapid augmentation of
synaptic efficacy in response to high frequency conditioning
pulses.
This conclusion was further complemented by a study on
mice where brain glycogen synthase (GS) was knocked out.
Biochemical assay revealed that liver and muscle glycogen were
unaffected. In these knockout animals learning and memory
was impaired compared to control animals (Duran et al., 2013).
Whilst initially in agreement with the previous studies, these data
must be considered in the context of the role brain glycogen
plays during physiological activity. The data suggests that only
learning and memory were affected, since animals appeared to
be normal, suggesting that brain glycogen is not vital for life,
and that its absence does not lead to any significant observable
pathology. Obviously more detailed studies on the effect of brain
GS knockouts are required.
GLYCOGEN AND EXERCISE
A role for glycogen during exercise is emerging. Its role
as an energy reserve has important consequences during
exercise with skeletal muscle glycogen used to provide energy.
The effects, if any, of exercise on brain glycogen were
unknown. Initial studies demonstrated that in rats exercising
on a treadmill, the skeletal muscle glycogen fell by up to
90%, but super-compensated to ∼45% after 24 h recovery.
A similar scenario occurred in the brain, with a decrease
of over 50%, with regional specific decreases, followed by
super-compensation (Matsui et al., 2012). Interestingly with
substantial exercise training the brain glycogen baseline level
increased, which may be due to the increased energy demands
required by the brain during exercise. However in these studies
there was significant systemic hypoglycemia. Thus experiments
were carried out in animals in which no hypoglycemia was
achieved. In this instance brain glycogen fell, but lactate in
the brain increased, implying glycogen plays a role in the
brain during exercise that is not affected by hypoglycemia.
Exercise results in increased serotonin turnover, which may
promote glycogenolysis (Matsui et al., 2015). The same group
have reported that type 2 diabetic patients had higher glycogen
in the hippocampus, hypothalamus and cortex, and that
MCT2 protein levels decreased, suggesting less efficient lactate
shuttling (Shima et al., 2016). This effect has been correlated
with exercise, which was shown to increase glycogen levels,
MCT2 expression and improve cognitive performance. Thus
these data support a link between glycogen levels and cognitive
performance.
CONCLUSION
The role(s) of nervous system glycogen are slowly emerging. Far
from being a mere metabolic curiosity, it appears to act as an
energy buffer, capable of the rapid delivery of the energy substrate
lactate, to fuel neural function. Established occasions when this
occurs are during the absence of glucose, or during hypoglycemia
where glycogen derived lactate acts as a supplemental energy
substrate to fuel neuronal function. As such a balance appears
to be struck between ambient glucose and glycogen-derived
lactate, when the former, is insufficient tomeet immediate energy
requirements delivery of the latter is increased. Brain glycogen
also plays a pivotal role in learning and memory, where it’s
presence is an absolute requirement for the transformation of
short term learning into storage as memories. As such glycogen
is positioned to play the key role as a buffer to supply energy
substrate for short term increases in energy demand as occurs
during the cellular mechanisms underlying LTP.
AUTHOR CONTRIBUTIONS
AMB and BRR conceived the review; edited the final version of
the manuscript. AEW, LR and AMB wrote the first draft of the
manuscript.
FUNDING
The review was funded in part by the University of Nottingham.
REFERENCES
Abi-Saab, W. M., Maggs, D. G., Jones, T., Jacob, R., Srihari, V., Thompson, J.,
et al. (2002). Striking differences in glucose and lactate levels between
brain extracellular fluid and plasma in conscious human subjects: effects of
hyperglycemia and hypoglycemia. J. Cereb. Blood Flow Metab. 22, 271–279.
doi: 10.1097/00004647-200203000-00004
Ames, A. III. (2000). CNS energy metabolism as related to
function. Brain Res. Rev. 34, 42–68. doi: 10.1016/s0165-0173(00)0
0038-2
Frontiers in Molecular Neuroscience | www.frontiersin.org 8 March 2017 | Volume 10 | Article 73
Waitt et al. Nervous System Glycogen
Aubert, A., Costalat, R., Magistretti, P. J., and Pellerin, L. (2005). Brain lactate
kinetics: modeling evidence for neuronal lactate uptake upon activation.
Proc. Natl. Acad. Sci. U S A 102, 16448–16453. doi: 10.1073/pnas.05054
27102
Brown, A. M., Baltan Tekkok, S., and Ransom, B. R. (2004). Energy transfer from
astrocytes to axons: the role of CNS glycogen. Neurochem. Int. 45, 529–536.
doi: 10.1016/j.neuint.2003.11.005
Brown, A. M., Evans, R. D., Black, J., and Ransom, B. R. (2012). Schwann
cell glycogen selectively supports myelinated axon function. Ann. Neurol. 72,
406–418. doi: 10.1002/ana.23607
Brown, A. M., Tekkök, S. B., and Ransom, B. R. (2003). Glycogen regulation
and functional role in mouse white matter. J. Physiol. 549, 501–512.
doi: 10.1113/jphysiol.2003.042416
Cali, C., Baghabra, J., Boges, D. J., Holst, G. R., Kreshuk, A., Hamprecht, F. A.,
et al. (2016). Three-dimensional immersive virtual reality for studying cellular
compartments in 3D models from EM preparations of neural tissues. J. Comp.
Neurol. 524, 23–38. doi: 10.1002/cne.23852
Cataldo, A. M., and Broadwell, R. D. (1986). Cytochemical identification of
cerebral glycogen and glucose-6-phosphatase activity under normal and
experimental conditions. I. Neurons and glia. J. Electron Microsc. Tech. 3,
413–437. doi: 10.1002/jemt.1060030406
Champe, P. C., and Harvey, R. A. (2008). Biochemistry. Baltimore, MD: Lippincott
Williams &Wilkins.
Chih, C.-P., Lipton, P., and Roberts, E. L. (2001). Do active cerebral neurons
really use lactate rather than glucose? Trends Neurosci. 24, 573–578.
doi: 10.1016/s0166-2236(00)01920-2
Chih, C.-P., and Roberts, E. L. (2003). Energy substrates for neurons during neural
activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis.
J. Cereb. Blood Flow Metab. 23, 1263–1281. doi: 10.1097/01.wcb.0000081369.
51727.6f
Choi, H. B., Gordon, G. R., Zhou, N., Tai, C., Rungta, R. L., Martinez, J.,
et al. (2012). Metabolic communication between astrocytes and neurons
via bicarbonate-responsive soluble adenylyl cyclase. Neuron 75, 1094–1104.
doi: 10.1016/j.neuron.2012.08.032
Connors, B. W., Ransom, B. R., Kunis, D. M., and Gutnick, M. J. (1982). Activity-
dependent K+ accumulation in the developing rat optic nerve. Science 216,
1341–1343. doi: 10.1126/science.7079771
Cryer, P. E. (2002). Hypoglycaemia: the limiting factor in the glycaemic
management of type I and type II diabetes. Diabetologia 45, 937–948.
doi: 10.1007/s00125-002-0822-9
Cummins, K. L., Perkel, D. H., and Dorfman, L. J. (1979). Nerve fiber
conduction-velocity distributions. I. Estimation based on the single-fiber
and compound action potentials. Electroencephalogr. Clin. Neurophysiol. 46,
634–646. doi: 10.1016/0013-4694(79)90101-9
Dalsgaard, M. K. (2006). Fuelling cerebral activity in exercising man. J. Cereb.
Blood Flow Metab. 26, 731–750. doi: 10.1038/sj.jcbfm.9600256
Dalsgaard, M. K., Quistorff, B., Danielsen, E. R., Selmer, C., Vogelsang, T., and
Secher, N. H. (2004). A reduced cerebral metabolic ratio in exercise reflects
metabolism and not accumulation of lactate within the human brain. J. Physiol.
554, 571–578. doi: 10.1113/jphysiol.2003.055053
Dienel, G. A. (2009). ‘‘Energy metabolism in the brain,’’ in From Molecules to
Networks: An Introduction to Cellular and Molecular Neuroscience, 2nd Edn.
eds J. H. Byrne and J. L. Roberts (New York, NY: Academic Press), 49–110.
Dienel, G. A. (2010). Astrocytes are ‘good scouts’: being prepared also
helps neighboring neurons. J. Cereb. Blood Flow Metab. 30, 1893–1894.
doi: 10.1038/jcbfm.2010.152
Dienel, G. A., and Hertz, L. (2001). Glucose and lactate metabolism during brain
activation. J. Neurosci. Res. 66, 824–838. doi: 10.1002/jnr.10079
DiNuzzo, M., Mangia, S., Maraviglia, B., and Giove, F. (2010). Glycogenolysis
in astrocytes supports blood-borne glucose channeling not glycogen-
derived lactate shuttling to neurons: evidence from mathematical modeling.
J. Cereb. Blood Flow Metab. 30, 1895–1904. doi: 10.1038/jcbfm.20
10.151
Domènech-Estévez, E., Baloui, H., Repond, C., Rosafio, K., Médard, J.-J.,
Tricaud, N., et al. (2015). Distribution of monocarboxylate transporters in
the peripheral nervous system suggests putative roles in lactate shuttling
and myelination. J. Neurosci. 35, 4151–4156. doi: 10.1523/JNEUROSCI.353
4-14.2015
Dringen, R., Gebhardt, R., and Hamprecht, B. (1993a). Glycogen in astrocytes:
possible function as lactate supply for neighboring cells. Brain Res. 623,
208–214. doi: 10.1016/0006-8993(93)91429-v
Dringen, R., Schmoll, D., Cesar, M., and Hamprecht, B. (1993b). Incorporation of
radioactivity from [14C] lactate into the glycogen of cultured mouse astroglial
cells. Evidence for gluconeogenesis in brain cells. Biol. Chem. Hoppe Seyler 374,
343–347. doi: 10.1515/bchm3.1993.374.1-6.343
Dringen, R., Peters, H.,Wiesinger, H., andHamprecht, B. (1995). Lactate transport
in cultured glial cells. Dev. Neurosci. 17, 63–69. doi: 10.1159/000111275
Duran, J., Saez, I., Gruart, A., Guinovart, J. J., and Delgado-Garcia, J. M. (2013).
Impairment in long-term memory formation and learning-dependent synaptic
plasticity in mice lacking glycogen synthase in the brain. J. Cereb. Blood Flow
Metab. 33, 550–556. doi: 10.1038/jcbfm.2012.200
Dwyer, D. S. (2002). Glucose Metabolism in the Brain. London: Academic Press.
Frier, B. M., and Fisher, B. M. (2007). Hypoglycaemia in Clinical Diabetes. New
York, NY: John Wiley & Sons, Ltd.
Fryer, K. L., and Brown, A. M. (2015). Pluralistic roles for glycogen in the
central and peripheral nervous systems. Metab. Brain Dis. 30, 299–306.
doi: 10.1007/s11011-014-9516-5
Gibbs, M. E., Anderson, D. G., and Hertz, L. (2006a). Inhibition of
glycogenolysis in astrocytes interrupts memory consolidation in young
chickens. Glia 54, 214–222. doi: 10.1002/glia.20377
Gibbs, M. E., O’Dowd, B. S., Hertz, E., and Hertz, L. (2006b). Astrocytic energy
metabolism consolidates memory in young chicks. Neuroscience 141, 9–13.
doi: 10.1016/j.neuroscience.2006.04.038
Gordon, G. R., Choi, H. B., Rungta, R. L., Ellis-Davies, G. C., and MacVicar, B. A.
(2008). Brain metabolism dictates the polarity of astrocyte control over
arterioles. Nature 456, 745–749. doi: 10.1038/nature07525
Hertz, L., Gibbs, M. E., O’Dowd, B. S., Sedman, G. L., Robinson, S. R., Sykova, E.,
et al. (1996). Astrocyte-neuron interaction during one-trial aversive learning
in the neonate chick. Neurosci. Biobehav. Rev. 20, 537–551. doi: 10.1016/0149-
7634(95)00020-8
Hertz, L., O’Dowd, B. S., Ng, K. T., and Gibbs, M. E. (2003). Reciprocal
changes in forebrain contents of glycogen and of glutamate/glutamine during
early memory consolidation in the day-old chick. Brain Res. 994, 226–233.
doi: 10.1016/j.brainres.2003.09.043
Hof, P. R., Pascale, E., and Magistretti, P. J. (1988). K+ at concentrations reached
in the extracellular space during neuronal activity promotes a Ca2+-dependent
glycogen hydrolysis in mouse cerebral cortex. J. Neurosci. 8, 1922–1928.
Hoppe, D., Chvatal, A., Kettenmann, H., Orkand, R. K., and Ransom, B. R. (1991).
Characteristics of activity-dependent potassium accumulation in mammalian
peripheral nerve in vitro. Brain Res. 552, 106–112. doi: 10.1016/0006-
8993(91)90666-j
Kalichman,M.W., Powell, H. C., andMizisin, A. P. (1998). Reactive, degenerative,
and proliferative Schwann cell responses in experimental galactose and human
diabetic neuropathy. Acta Neuropathol. 95, 47–56. doi: 10.1007/s004010050764
Kandel, E. R., Schwartz, J. H., and Jessell, T. M. (2000). Principles of Neural Science.
New York, NY: McGraw-Hill.
Katsuragi, S., Shimoji, A., Watanabe, K., and Miyakawa, T. (1988). Pathological
findings of the sural nerve in mitochondrial encephalomyopathy. Jpn.
J. Psychiatry Neurol. 42, 307–313. doi: 10.1111/j.1440-1819.1988.tb01981.x
Kettenmann, H., and Grantyn, R. (1992). Practical Electrophysiological Methods.
New York, NY: Wiley Liss.
Koizumi, J. (1974). Glycogen in the central nervous system. Prog. Histochem.
Cytochem. 6, 1–35. doi: 10.1016/s0079-6336(74)80003-3
Koizumi, J., and Shiraishi, H. (1970). Ultrastructural appearance of glycogen in
the hypothalamus of the rabbit following chlorpromazine administration. Exp.
Brain Res. 10, 276–282. doi: 10.1007/bf00235051
Landon, D. N. (1976). The Peripheral Nerve. London: Wiley & Sons.
Lee, Y., Morrison, B. M., Li, Y., Lengacher, S., Farah, M. H., Hoffman, P. N.,
et al. (2012). Oligodendroglia metabolically support axons and contribute
to neurodegeneration. Nature 487, 443–448. doi: 10.1038/nature
11314
Magistretti, P. J., and Pellerin, L. (1997). Metabolic coupling during activation. A
cellular view. Adv. Exp. Med. Biol. 413, 161–166. doi: 10.1007/978-1-4899-00
56-2_18
Malenka, R. C. (2003). The long-term potential of LTP. Nat. Rev. Neurosci. 4,
923–926. doi: 10.1038/nrn1258
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 March 2017 | Volume 10 | Article 73
Waitt et al. Nervous System Glycogen
Matsui, T., Ishikawa, T., Ito, H., Okamoto, M., Inoue, K., Lee, M. C., et al. (2012).
Brain glycogen supercompensation following exhaustive exercise. J. Physiol.
590, 607–616. doi: 10.1113/jphysiol.2011.217919
Matsui, T., Soya, S., Kawanaka, K., and Soya, H. (2015). Brain glycogen decreases
during intense exercise without hypoglycemia: the possible involvement of
serotonin. Neurochem. Res. 40, 1333–1340. doi: 10.1007/s11064-015-1594-1
Oe, Y., Baba, O., Ashida, H., Nakamura, K. C., and Hirase, H. (2016). Glycogen
distribution in the microwave-fixed mouse brain reveals heterogeneous
astrocytic patterns. Glia 64, 1532–1545. doi: 10.1002/glia.23020
Passonneau, J. V., Gatfield, P. D., Schulz, D. W., and Lowry, O. H. (1967). An
enzymic method for measurement of glycogen. Anal. Biochem. 19, 315–326.
doi: 10.1016/0003-2697(67)90167-4
Pellerin, L., and Magistretti, P. J. (1994). Glutamate uptake into astrocytes
stimulates aerobic glycolysis: a mechanism coupling neuronal activity
to glucose utilization. Proc. Natl. Acad. Sci. U S A 91, 10625–10629.
doi: 10.1073/pnas.91.22.10625
Pellerin, L., andMagistretti, P. J. (2003). Food for thought: challenging the dogmas.
J. Cereb. Blood Flow Metab. 23, 1282–1286. doi: 10.1097/01.WCB.0000096064.
12129.3d
Pellerin, L., and Magistretti, P. J. (2012). Sweet sixteen for ANLS. J. Cereb. Blood
Flow Metab. 32, 1152–1166. doi: 10.1038/jcbfm.2011.149
Perge, J. A., Niven, J. E., Mugnaini, E., Balasubramanian, V., and Sterling, P.
(2012). Why do axons differ in caliber? J. Neurosci. 32, 626–638.
doi: 10.1523/JNEUROSCI.4254-11.2012
Pfeiffer-Guglielmi, B., Coles, J. A., Francke, M., Reichenbach, A., Fleckenstein, B.,
Jung, G., et al. (2006). Immunocytochemical analysis of rat vagus nerve by
antibodies against glycogen phosphorylase isozymes. Brain Res. 1110, 23–29.
doi: 10.1016/j.brainres.2006.06.080
Pfeiffer-Guglielmi, B., Francke, M., Reichenbach, A., and Hamprecht, B. (2007).
Glycogen phosphorylase isozymes and energy metabolism in the rat peripheral
nervous system—an immunocytochemical study. Brain Res. 1136, 20–27.
doi: 10.1016/j.brainres.2006.12.037
Phelps, C. H. (1972). Barbiturate-induced glycogen accumulation in brain.
An electron microscopic study. Brain Res. 39, 225–234. doi: 10.1016/0006-
8993(72)90797-4
Powell, H. C., Haas, R., Hall, C. L., Wolff, J. A., Nyhan, W., and Brown, B. I.
(1985). Peripheral nerve in type III glycogenosis: selective involvement of
unmyelinated fiber Schwann cells.Muscle Nerve 8, 667–671. doi: 10.1002/mus.
880080808
Ransom, B. R., and Fern, R. (1997). Does astrocytic glycogen benefit axon function
and survival in CNSwhitematter during glucose deprivation?Glia 21, 134–141.
doi: 10.1002/(SICI)1098-1136(199709)21:1<134::AID-GLIA15>3.3.CO;2-P
Ransom, C. B., Ransom, B. R., and Sontheimer, H. (2000). Activity-dependent
extracellular K+ accumulation in rat optic nerve: the role of glial and axonal
Na+ pumps. J. Physiol. 522, 427–442. doi: 10.1111/j.1469-7793.2000.00427.x
Ransom, B. R., Waxman, S. G., and Stys, P. K. (1994). ‘‘Anoxic injury of central
myelinated axons: nonsynaptic ionic mechanisms,’’ in Cerebral Ischemia and
Basic Mechanisms, eds A. Hartman, F. Yatsu and W. Kuschinsky (Heidelberg:
Springer-Verlag), 77–90.
Saez, I., Duran, J., Sinadinos, C., Beltran, A., Yanes, O., Tevy, M. F., et al. (2014).
Neurons have an active glycogen metabolism that contributes to tolerance to
hypoxia. J. Cereb. Blood Flow Metab. 34, 945–955. doi: 10.1038/jcbfm.2014.33
Shima, T., Jesmin, S., Matsui, T., Soya, M., and Soya, H. (2016). Differential
effects of type 2 diabetes on brain glycometabolism in rats: focus on glycogen
and monocarboxylate transporter 2. J. Physiol. Sci. doi: 10.1007/s12576-016-0
508-6 [Epub ahead of print].
Shulman, R. G., Hyder, F., and Rothman, D. L. (2001). Cerebral energetics and the
glycogen shunt: neurochemical basis of functional imaging. Proc. Natl. Acad.
Sci. U S A 98, 6417–6422. doi: 10.1073/pnas.101129298
Sickmann, H. M., Schousboe, A., Fosgerau, K., and Waagepetersen, H. S. (2005).
Compartmentation of lactate originating from glycogen and glucose in cultured
astrocytes. Neurochem. Res. 30, 1295–1304. doi: 10.1007/s11064-005-8801-4
Sorg, O., and Magistretti, P. J. (1991). Characterization of the glycogenolysis
elicited by vasoactive intestinal peptide, noradrenaline and adenosine in
primary cultures of mouse cerebral cortical astrocytes. Brain Res. 563, 227–233.
doi: 10.1016/0006-8993(91)91538-c
Sotelo-Hitschfeld, T., Niemeyer, M. I., Mächler, P., Ruminot, I., Lerchundi, R.,
Wyss, M. T., et al. (2015). Channel-mediated lactate release by K+-stimulated
astrocytes. J. Neurosci. 35, 4168–4178. doi: 10.1523/JNEUROSCI.5036-14.2015
Stryer, L. (1995). Biochemistry. New York, NY: W.H. Freeman and Co.
Stys, P. K., Ransom, B. R., and Waxman, S. G. (1991). Compound action potential
of nerve recorded by suction electrode: a theoretical and experimental analysis.
Brain Res. 546, 18–32. doi: 10.1016/0006-8993(91)91154-s
Suzuki, A., Stern, S. A., Bozdagi, O., Huntley, G. W., Walker, R. H.,
Magistretti, P. J., et al. (2011). Astrocyte-neuron lactate transport is required
for long-term memory formation. Cell 144, 810–823. doi: 10.1016/j.cell.2011.
02.018
Swanson, R. A., and Choi, D. W. (1993). Glial glycogen stores affect neuronal
survival during glucose deprivation in vitro. J. Cereb. Blood Flow Metab. 13,
162–169. doi: 10.1097/00008506-199304000-00017
Taubenfeld, S. M., Milekic, M. H., Monti, B., and Alberini, C. M. (2001).
The consolidation of new but not reactivated memory requires hippocampal
C/EBPβ. Nat. Neurosci. 4, 813–818. doi: 10.1038/90520
Tekkok, S. B., Brown, A. M., Westenbroek, R., Pellerin, L., and Ransom, B. R.
(2005). Transfer of glycogen-derived lactate from astrocytes to axons via
specific monocarboxylate transporters supports mouse optic nerve activity.
J. Neurosci. Res. 81, 644–652. doi: 10.1002/jnr.20573
Tsacopoulos, M., Veuthey, A. L., Saravelos, S. G., Perrottet, P., and Tsoupras, G.
(1994). Glial cells transform glucose to alanine, which fuels the neurons in the
honeybee retina. J. Neurosci. 14, 1339–1351.
Vilchez, D., Ros, S., Cifuentes, D., Pujadas, L., Vallès, J., García-Fojeda, B.,
et al. (2007). Mechanism suppressing glycogen synthesis in neurons and its
demise in progressive myoclonus epilepsy. Nat. Neurosci. 10, 1407–1413.
doi: 10.1038/nn1998
Wender, R., Brown, A. M., Fern, R., Swanson, R. A., Farrell, K., and Ransom, B. R.
(2000). Astrocytic glycogen influences axon function and survival during
glucose deprivation in central white matter. J. Neurosci. 20, 6804–6810.
Whatley, S. A., Hall, C., and Lim, L. (1981). Hypothalamic neurons in dissociated
cell culture: the mechanism of increased survival times in the presence of
non-neuronal cells. J. Neurochem. 36, 2052–2056. doi: 10.1111/j.1471-4159.
1981.tb10833.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Waitt, Reed, Ransom and Brown. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution and reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 10 March 2017 | Volume 10 | Article 73
